학술논문
Discovery of YK-029A, a novel mutant EGFR inhibitor targeting both T790 M and exon 20 insertion mutations, as a treatment for NSCLC
Document Type
Article
Author
Source
In European Journal of Medicinal Chemistry 5 October 2023 258
Subject
Language
ISSN
0223-5234